Option Care Hlth logo

Option Care Hlth

Stock
Stock
Ticker: OPCH
OPCH

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Option Care Hlth is $3.52B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Option Care Hlth is 17.77. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Option Care Hlth's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.322. EPS indicates the company's profitability on a per-share basis.
Currently, 14 analysts cover Option Care Hlth's stock, with a consensus target price of $28.58. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Option Care Hlth reported a revenue of $5.69B.
Option Care Hlth's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $405.09M. EBITDA measures the company's overall financial performance.
Option Care Hlth has a free cash flow of $303.85M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Option Care Hlth employs approximately 6,528 people. It operates in the Health Care sector, specifically within the Medical/ Nursing Services industry.
The free float of Option Care Hlth is 147.15M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$3.52B
EPS (TTM) 
$1.322
Free Float 
147.15M
P/E ratio (TTM) 
17.77
Revenue (TTM) 
$5.69B
EBITDA (TTM) 
$405.09M
Free Cashflow (TTM) 
$303.85M

Pricing

1D span
$23.13$24.02
52W span
$18.02$36.79

Analyst Ratings

The price target is $28.58 and the stock is covered by 14 analysts.

Buy

9

Hold

5

Sell

0

Information

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Employees
6,528
Industries
Medical/ Nursing Services
Sector
Health Care

Identifier

Primary Ticker
OPCH

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation